MedTrace Logo

Steroids in Treatment of Viral Encephalitis

NCT04103684 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-01-29

No results posted yet for this study

Summary

acute viral encephalitis is used to describe restricted CNS involvement (namely, involvement of the brain, sparing the meninges)

Conditions

  • Encephalitis, Viral

Interventions

DRUG

Methylprednisolone

30mg per kg per day for 5 days followed by course of oral prednisolone

DRUG

Dexamethasone

0.6mg per kg perday for 5 days

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-30
Primary Completion
2021-03-30
Completion
2021-08-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04103684 on ClinicalTrials.gov